Ashland expands viatel bioresorbable polymers offering for medical devices
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
This project is supported by the Irish Government through IDA Ireland
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
The capital expansion program commenced in June 2022 and is expected to complete in 2024
Agreement further expands Aptar Pharma’s leading position in nasal delivery solutions and addresses significant unmet needs of delivering drugs locally over extended periods
The company’s largest center for medical device applications, serving the entire Asian market
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
Subscribe To Our Newsletter & Stay Updated